Our Partners

Biologics are medicines derived from living organisms or their components. They can include proteins, antibodies, or nucleic acids and are used to treat various diseases such as cancer, autoimmune disorders, and inflammatory conditions.

Synergist Medical provides OrthoBiologics - substances derived from the body's own tissues or from substances created in the laboratory. They are used to help heal injuries more quickly. Orthobiologics can include:

1. **Bone Marrow Aspirate Concentrate (BMAC)**: A concentrate of cells derived from bone marrow, which contains stem cells and growth factors that promote tissue repair and regeneration.

2. **Platelet-Rich Plasma (PRP)**: A concentration of platelets obtained from the patient's own blood, which contains growth factors that stimulate tissue healing and regeneration.

3. **Bone Grafts**: Transplanted bone tissue, either from the patient's own body (autograft), a donor (allograft), or synthetic materials, used to promote bone healing and fusion in orthopedic surgeries.

4. **Cartilage Repair Products**: Substances used to repair damaged cartilage in joints, such as autologous chondrocyte implantation (ACI) or matrix-induced autologous chondrocyte implantation (MACI), which involve transplanting the patient's own cartilage cells.

5. **Viscosupplementation**: Injections of hyaluronic acid derivatives into joints to improve lubrication and reduce pain in conditions such as osteoarthritis.

6. **Growth Factors**: Naturally occurring proteins that stimulate cell growth, proliferation, and differentiation, often used in conjunction with other orthobiologics to enhance tissue repair.

Orthobiologics offer the potential to accelerate healing and improve outcomes in orthopedic conditions such as fractures, ligament injuries, tendonitis, and osteoarthritis. However, their effectiveness can vary depending on factors such as the type and severity of the injury, the patient's overall health, and the specific orthobiologic used.

Orthobiologics offer several potential benefits compared to traditional treatments:

1. **Natural Healing**: Orthobiologics utilize substances derived from the patient's own body or from natural sources, such as bone marrow or blood, promoting a more natural healing process.

2. **Reduced Risk of Rejection**: Because orthobiologics often come from the patient's own tissues or are processed to reduce immunogenicity, there is a lower risk of rejection or adverse immune reactions compared to traditional treatments that may involve foreign materials.

3. **Enhanced Tissue Regeneration**: Orthobiologics contain growth factors, stem cells, and other bioactive molecules that can stimulate tissue regeneration and repair, potentially leading to improved outcomes and faster recovery times.

4. **Minimally Invasive**: Many orthobiologic treatments are delivered through minimally invasive procedures, such as injections or arthroscopic surgery, which can result in less tissue damage, reduced pain, and faster recovery compared to traditional open surgeries.

5. **Long-Term Benefits**: Orthobiologics have the potential to provide long-lasting benefits by addressing the underlying causes of musculoskeletal conditions, such as cartilage damage or ligament injuries, rather than just managing symptoms temporarily.

6. **Customized Treatment**: Orthobiologic therapies can be tailored to the individual patient's needs, with the option to use autologous (patient's own) tissues or specific formulations of growth factors, depending on the nature and severity of the injury or condition.

While orthobiologics offer promising advantages, it's important to note that they may not be suitable for all patients or conditions. Additionally, more research is needed to fully understand their effectiveness and long-term outcomes compared to traditional treatments. As with any medical intervention, the decision to use orthobiologics should be made in consultation with a qualified healthcare provider based on the individual patient's circumstances and preferences.

Orthobiologics are used for various purposes in the field of orthopedics and regenerative medicine. Some common uses include:

1. **Promoting Bone Healing**: Orthobiologics such as bone grafts, bone marrow aspirate concentrate (BMAC), and bone morphogenetic proteins (BMPs) are used to promote bone healing in fractures, non-unions, and spinal fusion surgeries.

2. **Repairing Cartilage**: Orthobiologics like autologous chondrocyte implantation (ACI), matrix-induced autologous chondrocyte implantation (MACI), and particulated juvenile cartilage (PJAC) are used to repair damaged cartilage in joints, particularly in cases of focal cartilage defects or osteochondral lesions.

3. **Alleviating Joint Pain**: Orthobiologics such as hyaluronic acid injections (viscosupplementation) and platelet-rich plasma (PRP) injections are used to alleviate pain and improve joint function in conditions such as osteoarthritis.

4. **Enhancing Soft Tissue Healing**: Orthobiologics are used to promote healing and repair of soft tissue injuries including ligament sprains, tendonitis, muscle strains, and rotator cuff tears.

5. **Facilitating Dental Implants**: Orthobiologics like bone grafts and growth factors are used in dental implant procedures to augment bone volume, promote bone healing, and facilitate implant integration.

6. **Supporting Spinal Fusion**: Orthobiologics are utilized in spinal fusion surgeries to promote bone growth and stability, particularly in cases of degenerative disc disease, spinal fractures, or spinal deformities.

7. **Improving Wound Healing**: Orthobiologics such as platelet-rich plasma (PRP) may be used to facilitate wound healing in chronic, non-healing wounds by promoting tissue regeneration and angiogenesis.

8. **Enhancing Recovery from Sports Injuries**: Orthobiologics can aid in the recovery from sports-related injuries such as ligament tears, muscle strains, stress fractures, and cartilage damage by promoting tissue repair and regeneration.

These are just a few examples of the diverse applications of orthobiologics. The specific use of orthobiologics will depend on the individual patient's condition, the type and severity of the injury or condition, and the treatment goals.

orthobiologics are considered safe when used appropriately and administered by qualified healthcare professionals. However, like any medical treatment, they may carry potential risks and side effects. Here are some factors to consider regarding the safety of orthobiologics:

1. **Source of Materials**: Orthobiologics derived from the patient's own tissues, such as autologous bone marrow aspirate or platelet-rich plasma (PRP), generally have a lower risk of adverse reactions compared to those derived from other sources.

2. **Infection Risk**: There is a risk of infection associated with any injection or surgical procedure, including those involving orthobiologics. Proper sterile techniques must be followed to minimize this risk.

3. **Immunogenicity**: Some orthobiologics may elicit immune responses in certain individuals, particularly those derived from non-autologous (donor) sources. This can lead to allergic reactions or immune rejection of the treatment.

4. **Local Tissue Reactions**: Injection of orthobiologics may cause local reactions at the injection site, such as pain, swelling, redness, or bruising. These reactions are usually mild and temporary.

5. **Systemic Effects**: In rare cases, orthobiologics may cause systemic effects such as allergic reactions, blood clotting disorders, or alterations in blood pressure. These adverse effects are uncommon but can occur.

6. **Long-Term Safety Data**: While many orthobiologics have been used for years with favorable safety profiles, long-term data on the safety of newer orthobiologic treatments may be limited, especially for emerging therapies.

7. **Patient-specific Factors**: The safety of orthobiologics can vary depending on individual patient factors such as age, overall health status, medical history, and concomitant medications.

It's important for patients to discuss the potential risks and benefits of orthobiologic treatment with their healthcare provider before undergoing treatment. Providers can assess each patient's suitability for orthobiologic therapy and provide guidance on the most appropriate treatment options based on their specific needs and circumstances.

Coverage for orthobiologics by insurance can vary depending on several factors, including the specific orthobiologic treatment, the insurance provider, the patient's insurance plan, and the reason for the treatment. Here are some considerations regarding insurance coverage for orthobiologics:

1.**Off-label Use**: In some cases, orthobiologic treatments may be used off-label, meaning they are prescribed for conditions or purposes not specifically approved by regulatory authorities. Insurance coverage for off-label use may be less predictable and may require additional documentation or justification from the healthcare provider.

3. **Medical Necessity**: Insurance coverage for orthobiologics may be contingent on medical necessity, meaning the treatment is deemed necessary by the healthcare provider to address a specific medical condition or symptom. Insurance companies may require documentation of medical necessity before approving coverage.

4. **Pre-authorization Requirements**: Some insurance plans require pre-authorization or prior approval for certain medical treatments, including orthobiologics. This process typically involves submitting documentation from the healthcare provider to the insurance company to justify the need for the treatment.

5. **Coverage Limitations**: Insurance plans may have limitations or restrictions on coverage for orthobiologic treatments, such as caps on the number of treatments allowed per year, requirements for step therapy (trying other treatments before orthobiologics), or specific criteria for eligibility.

6. **Out-of-pocket Costs**: Even if orthobiologic treatment is covered by insurance, patients may still be responsible for out-of-pocket costs such as deductibles, co-payments, and co-insurance.

Patients should review their insurance policy documents, including coverage details and any exclusions or limitations related to orthobiologic treatments. Additionally, discussing coverage options with the healthcare provider and contacting the insurance company directly can help clarify insurance coverage for orthobiologic treatments.

Yes, there are several contraindications for orthobiologic treatment, meaning situations or conditions in which the use of orthobiologics may not be recommended or may pose risks to the patient. Contraindications can vary depending on the specific type of orthobiologic treatment and the individual patient's medical history and condition. Some common contraindications for orthobiologic treatment include:

1. **Active Infection**: Orthobiologic treatments should not be administered in the presence of an active infection at the treatment site or in the bloodstream. Doing so could exacerbate the infection or lead to further complications.

2. **Bleeding Disorders**: Patients with bleeding disorders or those taking anticoagulant medications may be at increased risk of bleeding complications with orthobiologic treatments, particularly those involving injections or surgical procedures.

3. **Allergies or Sensitivities**: Patients with known allergies or sensitivities to components of orthobiologics, such as proteins or preservatives, may experience allergic reactions when exposed to these treatments.

4. **Immunosuppression**: Patients with compromised immune systems, such as those receiving immunosuppressive therapy or undergoing chemotherapy, may be at increased risk of infection or inadequate healing with orthobiologic treatments.

5. **Pregnancy**: The safety of orthobiologic treatments during pregnancy has not been fully established, and their use may pose risks to the fetus. Pregnant women should consult with their healthcare provider before undergoing orthobiologic treatment.

6. **Severe Osteoporosis**: In patients with severe osteoporosis or other bone metabolic disorders, the use of orthobiologics may be contraindicated due to concerns about bone quality and healing potential.

7. **Advanced Age**: While age alone is not necessarily a contraindication for orthobiologic treatment, older adults may have comorbidities or reduced healing capacity that could affect treatment outcomes and increase the risk of complications.

8. **Uncontrolled Diabetes**: Patients with uncontrolled diabetes may have impaired wound healing and increased risk of infection, which could affect the safety and efficacy of orthobiologic treatments, particularly those involving surgery or injections.

9. **History of Cancer**: Certain orthobiologic treatments, such as growth factors or stem cell therapies, may stimulate cell proliferation and could theoretically promote tumor growth in patients with a history of cancer. The use of orthobiologics in these patients should be carefully evaluated on a case-by-case basis.

10. **Severe Cardiovascular Disease**: Patients with severe cardiovascular disease or other significant medical comorbidities may not be good candidates for orthobiologic treatments, particularly those involving surgery or significant tissue manipulation.

It's important for healthcare providers to thoroughly evaluate each patient's medical history, current condition, and potential risk factors before recommending orthobiologic treatment. Patients should also discuss any concerns or pre-existing conditions with their healthcare provider to determine the appropriateness of orthobiologic therapy for their individual circumstances.